Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW.
説明 | Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW. |
ターゲット&IC50 | CCR5:, HIV-1 (JRFL):0.1 nM, HIV-1 (Ba-L):0.4 nM, HIV-1 (MOKW):0.2 nM |
別名 | AK 602, GW 873140, GSK 873140 |
分子量 | 577.71 |
分子式 | C33H43N3O6 |
CAS No. | 461443-59-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aplaviroc 461443-59-4 Immunology/Inflammation Microbiology/Virology Proteases/Proteasome CCR HIV Protease AK 602 GW 873140 AK-602 AK602 GW-873140 GSK 873140 GSK-873140 GSK873140 GW873140 Inhibitor inhibitor inhibit